Huifeng Yun

17PUBLICATIONS
47CO-AUTHORS
Disease surveillanceEpidemiological methodsPreventative health careOccupational epidemiologySocio-economic development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 10, 2026
Age-specific Risk of Herpes Zoster in Immunocompetent Adults ≥18 Years-of-age-A Retrospective Cohort Study in the United States.

Rachel A Cohen, Driss Oraichi, Agnes Mwakingwe-Omari

|Mar 26, 2026
Age-Specific Risk of Herpes Zoster in Adults Aged ≥18 Years With Comorbid Conditions-A Retrospective Cohort Study in the United States.

Rachel A Cohen, Driss Oraichi, Agnes Mwakingwe-Omari

|Jan 30, 2026
Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis.

Adoración Navarro-Torné, Emmanuel Aris, Andrea Callegaro

|Aug 12, 2025
Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases.

Dagna Constenla, Germain Lonnet, Emmanuel Aris

|Aug 12, 2025
Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years.

Emily Rayens, Lina S Sy, Lei Qian

|Jun 28, 2025
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States.

Hung-Fu Tseng, Lina S Sy, Bradley K Ackerson

Pageof 3